Pharma Journalist - Page 19 of 923 -

Gilead Completes $7.8 Billion Arcellx Acquisition Deal

EU Approves Rhapsido for Chronic Hives Treatment

Lilly to Acquire Ajax in $2.3 Billion Deal

AstraZeneca, CSPC Partner on Next-Generation Obesity Therapies

AstraZeneca Pledges $15bn to Expand China R&D, Manufacturing

Repertoire, Lilly Team Up on Tolerizing Autoimmune Therapies

EMA Panel Backs Rezurock for Hard-to-Treat Chronic GVHD

FDA Grants Priority Review to Otsuka’s Novel ADHD Drug

Simcere, Boehringer Partner on Bispecific Antibody for IBD Treatment

Insilico and Qilu Forge AI-Driven Cardiometabolic Drug Partnership

Mirum Completes Bluejay Acquisition, Expands Rare Liver Disease Pipeline

FDA Reviews Weekly Subcutaneous Dosing Option for Eisai’s Alzheimer’s Drug

WuXi Biologics and HanchorBio Partner on Next-Generation Fusion Therapies